Click:   The Last Update Time:--

High

Supervisor of Doctorate Candidates
Supervisor of Master's Candidates
Name (Simplified Chinese):High
Name (English):High
Name (Pinyin):haohaihong
Professional Title:Professor
Status:Employed
Education Level:With Certificate of Graduation for Doctorate Study
Degree:博士
Business Address:华中农业大学国家兽药残留基准实验室118
E-Mail:
Alma Mater:华中农业大学
Teacher College:College of Animal Sciences & Technology / College of Veterinary Medicine
School/Department:动物科学技术学院、动物医学院
Discipline:Other specialties in Veterinary Medicine    Basic Veterinary Medicine    
Other Contact Information:

ZipCode:

PostalAddress:

Telephone:

Email:

Paper Publications
PK-PD Modeling and Optimal Dosing Regimen of Acetylkitasamycin against Streptococcus suis in Piglets
Release time:2022-03-03    Hits:

Impact Factor:4.639

DOI number:10.3390/antibiotics11020283

Journal:Antibiotics (Basel)

Key Words:Streptococcus suis, acetylkitasamycin, PK-PD, dosing regimen, PELF

Abstract:Streptococcus suis (S. suis) causes severe respiratory diseases in pigs and is also an important pathogen causing hidden dangers to public health and safety. Acetylkitasamycin is a new macrolide agent that has shown good activity to Gram-positive cocci such as Streptococcus. The purpose of this study was to perform pharmacokinetic–pharmacodynamic (PK-PD) modeling to formulate a dosing regimen of acetylkitasamycin for treatment of S. suis and to decrease the emergence of acetylkitasamycin-resistant S. suis. The minimal inhibitory concentration (MIC) of 110 S. suis isolates was determined by broth micro dilution method. The MIC50 of the 55 sensitive S. suis isolates was 1.21 μg/mL. The strain HB1607 with MIC close to MIC50 and high pathogenicity was used for the PK-PD experiments. The MIC and MBC of HB1607 in both MH broth and pulmonary epithelial lining fluid (PELF) was 1 and 2 μg/mL, respectively. The liquid chromatography–tandem mass spectrometry (LC-MS/MS) method was used to determine the concentration change of acetylkitasamycin in piglet plasma and PELF after intragastric administration of a single dose of 50 mg/kg b.w. acetylkitasamycin. The PK parameters were calculated by WinNolin software. The PK data showed that the maximum concentration (Cmax), peak time (Tmax), and area under the concentration–time curve (AUC) were 9.84 ± 0.39 μg/mL, 4.27 ± 0.19 h and 248.58 ± 21.17 h·μg/mL, respectively. Integration of the in vivo PK data and ex vivo PD data, an inhibition sigmoid Emax equation was established. The dosing regimen of acetylkitasamycin for the treatment S. suis infection established as 33.12 mg/kg b.w. every 12 h for 3 days. This study provided a reasonable dosing regimen for a new drug used in clinical treatment, which can effectively be used to treat S. suis infection and slow down the generation of drug resistance.

Co-author:Lingli Huang,Shuyu Xie,Yuanhu Pan,Wei Qu,Guyue Cheng,Zhenli Liu

First Author:Feng Mao,Anxiong Huang

Indexed by:Journal paper

Correspondence Author:Dapeng Peng,Haihong Hao

Volume:11

Issue:2

Page Number:283

Number of Words:4000

Translation or Not:no

Date of Publication:2022-02-01

Included Journals:SCI

Links to published journals:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868236/